Skip to content

Sepsis Clinical Decision Support [CDS] Master Enrollment Study Protocol

Sepsis Onset Warning System [SOWS] Master Enrollment Study Protocol

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05304728
Enrollment
40000
Registered
2022-03-31
Start date
2021-02-15
Completion date
2026-12-31
Last updated
2024-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Sepsis, Severe Sepsis Without Septic Shock

Brief summary

This protocol will collect real-world data retrospectively from the electronic health record (EHR) as data obtained from the delivery of routine medical care to develop a machine learning (ML)-based Clinical Decision Support (CDS) system for severe sepsis prediction and detection.

Detailed description

The purpose of this study is to gather data for the clinical development of the Sepsis Onset Warning System (SOWS) Software as Medical Device (SaMD) product to support a De Novo FDA submission and commercialization in the United States. Product development of SOWS is funded in part with federal funds from the Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority. Data will be obtained from passive prospective collection of patient encounter data throughout the duration of the planned study to support the product development life cycle activities associated with developing the Sepsis Onset Warning System (SOWS) for severe sepsis risk detection. Inputs from patient health records in combination with proprietary hematology parameters developed by Beckman Coulter, such as Monocyte Distribution Width (MDW), will be used. The SOWS tool will look to use clinical measurements which are commonly and reliably available in the EHR as structured data elements, such as heart rate, temperature, blood pressure, and laboratory results and account for changes in these values over time.

Interventions

None listed

Sponsors

Biomedical Advanced Research and Development Authority
CollaboratorFED
Beckman Coulter, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years

Inclusion criteria

* All races, ages and ethnicities * All patients admitted to the hospital or presenting to the Emergency Department

Exclusion criteria

* Patients not presenting to a hospital setting (e.g. urgent care, outpatient clinic excluded).

Design outcomes

Primary

MeasureTime frameDescription
Severe SepsisWithin 6 hours from presentation to the emergency departmentIdentify patients having Severe Sepsis with the use of electronic health data

Secondary

MeasureTime frameDescription
MortalityWithin 6hours from presentation to the emergency departmentHospital mortality at hospital for Severe Sepsis patients identified by algorithm using electronic health data as potential benefits for increased early detection of risk of severe sepsis
Length of StayWithin 6hours from presentation to the emergency departmentDetermine length of stay at hospital for Severe Sepsis patients identified by algorithm using electronic health data as potential benefits for increased early detection of risk of severe sepsis
Re-admission RatesWithin 6hours from presentation to the emergency departmentDetermine potential reduction of hospital readmission rates for Severe Sepsis patients identified by algorithm using electronic health data as potential benefits for increased early detection of risk of severe sepsis

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026